Atlas Venture
Venture Capital Est. 1980
USD 500M
Estimated FUM
- Type
- Venture Capital
- HQ
- Cambridge, MA, United States
- Founded
- 1980
- Focus
- Healthtech / Life Sciences
About
Atlas Venture is an early-stage venture capital firm that focuses on life science startups in the United States, in particular companies headquartered in Cambridge, Massachusetts. We are active investors that assist our companies position themselves for successful drug development and exits in all market environments. From its founding in 1980 until 2014, Atlas invested in both life sciences and technology, however since 2014, Atlas has focused exclusively on biotechnology.
Investment Focus
Focus Areas
Stages
Seed Series A Series B
Focus
Healthtech / Life Sciences
Specialist
Investment Geographies
Primary Markets
United States
Coverage
Country-focused Regions
North America
Coverage is a guide only.
Location
Headquarters
Cambridge, MA, United States
Office Presence
1 country
United States
1 known office
Cambridge, MA, United States (HQ)
Deals & Activity
Tracked Deals
8
Most common deal types
Unknown (8)
Deals by domain
Healthcare 1
Recent tracked deals
Generationbio
2026
Akerotx
2025 - Healthcare
Dayonebio
2021
Dyne Tx
2020
Be
Antaresrx
Accenttx
Visit Site
People also viewed
Foundry Group
Foundry Group is a Colorado-based venture firm that invests in early-stage and growth-stage companies headquartered in the US and Canada. Foundry Group also invests in select, newly-formed venture capital fund managers. Foundry Group formed in 2007 and originally focused on Seed and Series A investments. It raised a growth-stage fund in 2014 (Foundry Group Next), and a fund dedicated to investing in other venture funds (Foundry Group Next) in 2016.
Regardless of the size of our initial investment, the size and structure of our funds allow us to continue to fund portfolio companies through their entire financing lifecycles. In addition, our venture capital fund investments give us insight and access to a large number of venture-backed companies at varying stages while extending the reach of our overall network. In addition to providing capital, we leverage our experience in starting and growing companies, our expertise in the technology industry, and our network of relationships to help outstanding entrepreneurs and venture capital fund managers turn great ideas into great companies.
8VC
8VC is an early-stage venture capital firm based in San Francisco. 8VC's mantra is: 'the world is broken: let's fix it', and this defines our investment mantra. We look to invest in software, biotechnology, hardware, and other technology-enabled startups. We have raised separate seed stage, early-stage, co-invest and follow-on funds. 8VC was founded in 2015 by Joe Londsdale, Alex Kolicich, Jake Medwell, and Drew Oetting. We are based in San Francisco and invest throughout North America.
Venrock
Venrock is a venture capital firm headquartered in Palo Alto that focuses on disruptive early-stage technology startups. Venrock partners with entrepreneurs who have grand ambitions and want to tackle big, hard problems that most think impossible. Venrock today consists of two separate programs: a traditional venture capital program, focused on early stage investing in healthcare and technology companies; and a later-stage healthcare program, which implements a venture capital-like long-term approach to investment opportunities in small capitalization public companies and late-stage private healthcare companies.
Venrock was formed in 1969 as a venture arm of the Rockefeller family (the name Venrock being a compound of Venture and Rockefeller), who have a long history of venture-style investing dating back to the early 20th century.
Canaan Partners
Canaan Partners is an early-stage venture capital firm investing in technology and healthcare companies in the United States.
FirstMark Capital
FirstMark Capital is an early stage venture capital firm based in New York that primarily invests at the seed or Series A stage. We are proud to back the ambitious founders of the most iconic companies in the world. We provide our investee companies access to the FirstMark platform and resources, which we believe is powered by the largest network in venture capital.
FirstMark was founded in 2008 as a spinoff of Pequot Ventures, owned Pequot Capital Management.
Talu Ventures
Talu Ventures is an early stage technology investor in Australia, with a particular focus on biotechnology, medical devices and pharmaceuticals. Talu was founded in 2012 by three of the partners of CM Capital. Talu's founders have dedicated their careers to the IT and biotech industries and they understand the challenges of building companies from the ground up. In collaboration with Talu's Industry Advisors, portfolio companies can draw upon more than a century of leadership roles within a broad spectrum of successful companies. Talu has been the lead investor in more than 90 percent of its investments.